EYE 2.86% 18.0¢ nova eye medical limited

EYE Summary (August 2024): Incredibly Undervalued, page-110

  1. 10,176 Posts.
    lightbulb Created with Sketch. 1233
    Good point. Consistent with my comment that they don't have enough money to fund it to fruition, much less operate it as a business. You a business analyst?
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.